MedPath

Effects of Shenlingbaizhu powder on the efficacy of chemotherapy and the quality of life of patients with ovarian cancer based on intestinal microecology

Phase 1
Recruiting
Conditions
Ovarian cancer
Registration Number
ITMCTR2100004792
Lead Sponsor
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. The clinicopathological diagnosis was ovarian cancer;
2. Aged 18 to 65 years;
3. The patients whose survival time was more than 3 months were predicted;
4. We plan to stay in our hospital or chemotherapy for more than 3 cycles, including surgical and non-surgical patients. The operation is palliative resection and postoperative metastasis;
5. Understand and willing to participate in this study, voluntarily sign the informed consent for treatment.

Exclusion Criteria

1. Accompanied by severe infection, high fever, etc;
2. Receiving parenteral nutrition;
3. A large amount of hydrothorax and ascites and severe edema;
4. Patients with cardiovascular and cerebrovascular diseases, liver, kidney, immune and bone marrow dysfunction, psychosis and mental disorders;
5. The cognitive ability of the patients was poor, and they were unable to answer questions or fill in questionnaires.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Immune function test;Distribution of intestinal flora;Efficacy evaluation;
Secondary Outcome Measures
NameTimeMethod
Quality of life;Cancer fatigue test;Side effects;
© Copyright 2025. All Rights Reserved by MedPath